NEJM - Humoral Immune Response to SARS-CoV-2 in Iceland

NEJM - Humoral Immune Response to SARS-CoV-2 in Iceland

The New England Journal of MedicineOf the 1797 persons who had recovered from SARS-CoV-2 infection, 1107 of the 1215 who were tested (91.1%) were seropositive; antiviral antibody titers assayed by two pan-Ig assays increased during 2 months after...
WHO - Corticosteroids for COVID-19

WHO - Corticosteroids for COVID-19

World Health OrganizationThis guidance was developed in collaboration with the non-profit Magic Evidence Ecosystem Foundation (MAGIC), which provided methodologic support to develop and disseminate living guidance for COVID-19 drug treatments. We...
AMP - Coronavírus e Lei de Saúde Mental: Novos Desafios, Problemas Antigos

AMP - Coronavírus e Lei de Saúde Mental: Novos Desafios, Problemas Antigos

Acta Médica PortuguesaA pandemia COVID-19 poderá ter um impacto significativo na saúde mental da população em geral e, em particular, nas pessoas com doença mental grave. O medo de contrair a infeção, as alterações na rotina diária e a...
NEJM - Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

NEJM - Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

The New England Journal of MedicineRapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic. Although the current standard involves testing of nasopharyngeal swab specimens by quantitative...
BMJ - Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

BMJ - Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

The British Medical JournalTo characterise the clinical features of children and young people admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the UK and explore factors...
BMJ - Two metres or one: what is the evidence for physical distancing in covid-19?

BMJ - Two metres or one: what is the evidence for physical distancing in covid-19?

British Medical JournalPhysical distancing is an important part of measures to control covid-19, but exactly how far away and for how long contact is safe in different contexts is unclear. Rules that stipulate a single specific physical distance...
WHO - Advice on the use of masks for children in the community in the context of COVID-19

WHO - Advice on the use of masks for children in the community in the context of COVID-19

World Health OrganizationThis document provides guidance to decision makers, public and child health professionals to inform policy on the use of masks for children in the context of the COVID-19 pandemic. It does not address the use of masks for...
JAMA - Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women

JAMA - Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women

JAMA NETWORKConcern has been raised that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be transmitted to infants by breastfeeding. A number of organizations advise that women infected with SARS-CoV-2 may choose to breastfeed...
JAMA - Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial

JAMA - Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial

JAMA NETWORK

Does remdesivir provide a benefit on clinical status for patients hospitalized with moderate coronavirus disease 2019 (COVID-19) pneumonia?

ECDC - Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU/EEA and the United Kingdom

ECDC - Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU/EEA and the United Kingdom

European Centre for Disease Prevention and ControlDifferent population-wide testing approaches have already been used in various countries, including household testing, individual testing and the testing of incoming travellers, irrespective of...
JAMA - Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

JAMA - Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

JAMA NETWORK

 What are the safety and immunogenicity of an inactivated vaccine against coronavirus disease 2019 (COVID-19)?

THE LANCET - Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

THE LANCET - Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

The LancetSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome have been detected in Singapore and other countries. We investigated the...
THE LANCET - Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

THE LANCET - Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

The LancetTocilizumab, a monoclonal antibody directed against the interleukin-6 receptor, has been proposed to mitigate the cytokine storm syndrome associated with severe COVID-19. We aimed to investigate the association between tocilizumab...
BMJ - Management of post-acute covid-19 in primary care

BMJ - Management of post-acute covid-19 in primary care

British Medical JournalPost-acute covid-19 (“long covid”) seems to be a multisystem disease, sometimes occurring after a relatively mild acute illness. Clinical management requires a whole-patient perspective. This article, intended for...
Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization

Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization

Yale NewsA saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food...
Primeiro567810121314Último
Categorias

Categorias

Arquivo de Notícias

Arquivo